Table 6 Predictors of FT4 normalization among hyperthyroid patients attending UoGCSH
FT4 normalization | FT4 normalization | |||
|---|---|---|---|---|
CHR (95% CI) | p-value | AHR (95% CI) | p-value | |
Age (years) | 0.983 (0.970–0.996) | 0.009 | 0.999 (0.974–1.004) | 0.160 |
Duration of symptoms before treatment (months) | 0.998 (0.997–0.999) | 0.047 | 0.999 (0.997–1.000) | 0.140 |
PTU dose: initial | 1.002 (1.000–1.003) | 0.108 | 1.001 (0.999–1.003) | 0.447 |